JP2013543872A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013543872A5 JP2013543872A5 JP2013540105A JP2013540105A JP2013543872A5 JP 2013543872 A5 JP2013543872 A5 JP 2013543872A5 JP 2013540105 A JP2013540105 A JP 2013540105A JP 2013540105 A JP2013540105 A JP 2013540105A JP 2013543872 A5 JP2013543872 A5 JP 2013543872A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- interferon
- concentration
- stable
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 24
- 102000003996 Interferon-beta Human genes 0.000 claims 10
- 108090000467 Interferon-beta Proteins 0.000 claims 10
- 229960001388 interferon-beta Drugs 0.000 claims 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 3
- 229930006000 Sucrose Natural products 0.000 claims 3
- 239000005720 sucrose Substances 0.000 claims 3
- 108010005716 Interferon beta-1a Proteins 0.000 claims 2
- 108010005714 Interferon beta-1b Proteins 0.000 claims 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 2
- 229960004461 interferon beta-1a Drugs 0.000 claims 2
- 229960003161 interferon beta-1b Drugs 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical group [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- 238000013019 agitation Methods 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- 229950008882 polysorbate Drugs 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 235000017281 sodium acetate Nutrition 0.000 claims 1
- 239000001632 sodium acetate Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41629110P | 2010-11-22 | 2010-11-22 | |
| US61/416,291 | 2010-11-22 | ||
| PCT/US2011/061759 WO2012071366A1 (en) | 2010-11-22 | 2011-11-22 | Stable preserved compositions if interferon-beta |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013543872A JP2013543872A (ja) | 2013-12-09 |
| JP2013543872A5 true JP2013543872A5 (enExample) | 2014-01-30 |
Family
ID=46146183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013540105A Pending JP2013543872A (ja) | 2010-11-22 | 2011-11-22 | インターフェロン−βの安定に保存される組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20120269770A1 (enExample) |
| EP (1) | EP2643469A1 (enExample) |
| JP (1) | JP2013543872A (enExample) |
| AU (1) | AU2011331992A1 (enExample) |
| CA (1) | CA2818671A1 (enExample) |
| MX (1) | MX2013005699A (enExample) |
| WO (1) | WO2012071366A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014130811A1 (en) * | 2013-02-22 | 2014-08-28 | Biogen Idec Ma Inc | Interferon beta formulation |
| WO2016163764A2 (ko) * | 2015-04-07 | 2016-10-13 | 에이비온 주식회사 | 인터페론 베타 변이체의 안정화 제제 |
| FI126979B (en) * | 2016-02-29 | 2017-09-15 | Faron Pharmaceuticals Oy | Lyophilized pharmaceutical formulation and its use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1272252B (it) * | 1994-05-16 | 1997-06-16 | Applied Research Systems | Formulazioni liquide di interferone beta |
| US6887462B2 (en) * | 2001-04-09 | 2005-05-03 | Chiron Corporation | HSA-free formulations of interferon-beta |
| BRPI0510526A (pt) * | 2004-06-01 | 2007-10-30 | Ares Trading Sa | formulações lìquidas estabilizadas de interferon |
| CN101878043A (zh) * | 2007-12-20 | 2010-11-03 | 默克雪兰诺有限公司 | PEG-干扰素-β制剂 |
-
2011
- 2011-11-21 US US13/301,354 patent/US20120269770A1/en not_active Abandoned
- 2011-11-22 AU AU2011331992A patent/AU2011331992A1/en not_active Abandoned
- 2011-11-22 WO PCT/US2011/061759 patent/WO2012071366A1/en not_active Ceased
- 2011-11-22 MX MX2013005699A patent/MX2013005699A/es not_active Application Discontinuation
- 2011-11-22 CA CA2818671A patent/CA2818671A1/en not_active Abandoned
- 2011-11-22 EP EP11843556.9A patent/EP2643469A1/en not_active Withdrawn
- 2011-11-22 JP JP2013540105A patent/JP2013543872A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME02312B (me) | DERIVATI PIRAZOLOSPIROKETONA, NAMIJENJENI UPOTREBI KAO INHIBITORI ACETIL-CoA-KARBOKSILAZE | |
| ME02182B (me) | TERAPEUTSKA KOMBINACIJA KOJA SADRŽI DOLUTEGRAVIR, ABAKAVIR l LAMIVUDIN | |
| HRP20200434T1 (hr) | Stabilne vodene formulacije adalimumaba | |
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| BR112014011162A2 (pt) | derivados purínicos para o tratamento de infecções virais | |
| PH12013502549B1 (en) | Fused benzoxazepinones as ion channel modulators | |
| HRP20171175T1 (hr) | Novi triciklički spojevi | |
| JP2012092110A5 (enExample) | ||
| HRP20220455T1 (hr) | Modificirane aminokiseline koje sadrže azid grupu | |
| PH12014502778B1 (en) | Antibody formulation | |
| HRP20180425T1 (hr) | Čvrste kompozicije koje sadrže agonist glp-1 i sol n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline | |
| GEP20156263B (en) | Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for production and usage thereof | |
| MX381004B (es) | Composiciones de fenfluramina y métodos de preparación de las mismas. | |
| HRP20200332T1 (hr) | Modifikator eksenatida i njegova primjena | |
| HRP20171181T1 (hr) | Pripravak smole koji se može razblažiti u vodi | |
| JP2013543872A5 (enExample) | ||
| WO2015038689A3 (en) | Cationic antiseptic compositions | |
| JP2015519398A5 (enExample) | ||
| BR112013025368A8 (pt) | Medicamento, método para preparar um medicamento útil para reduzir danos por derrame em um sujeito com derrame, método para preparar um medicamento útil para reduzir a pressão sanguínea e reduzir danos por derrame em um sujeito com derrame | |
| JP2014533689A5 (enExample) | ||
| EA201291463A1 (ru) | Составы для инфузии лантибиотиков типа b | |
| JP2011042682A5 (enExample) | ||
| BR112014013723A8 (pt) | formas cristalinas da [(s)-1-carbamoil-2-(fenil-pirimidin-2-il-amino)-etil]-amida do ácido 2-(2-metil-amino-pirimidin-4-il)-1h-indol-5-carboxílico | |
| HRP20130983T1 (hr) | Derivati arilciklopropilacetamida, korisni kao aktivatori glukokinaze | |
| WO2012111934A3 (ko) | 데카스퍼뮴 프루티코숨 추출물을 함유하는 염증성 질환 또는 천식의 예방 및 치료용 약학적 조성물 |